Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Soy Protein and Reduced LDL Cholesterol

Research synthesisLow evidenceModerate effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Based on 3 studies, 2 showed beneficial effects of soy protein on reducing LDL cholesterol, with effect sizes ranging from small to moderate. The evidence shows moderate beneficial effects in patients with type 2 diabetic nephropathy at doses of approximately 35% soy protein in the diet, though one study found no effect at 40 g/day over 90 days. The median study duration is 90 days, but only 1 of 3 studies reported duration.

  • Effective dose range: 35% of diet as soy protein (approx. 40 g/day)
  • Studied populations: patients with type 2 diabetic nephropathy

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One of the beneficial studies is a systematic review that included soy protein as part of a diet, not as a standalone supplement, and the other beneficial study compared whey protein (not soy) to control while analyzing soy as part of a larger meta-analysis—so the direct evidence for soy protein alone is limited. The only RCT specifically testing soy protein (40 g/day for 90 days) found no significant effect on LDL cholesterol, which contradicts the beneficial findings from the higher-level analyses.

Generated Jun 11, 2026
Doses used in studies
  • %/day: 35 (median 35, IQR 3535) 1 study
  • g/day: 40 (median 40, IQR 4040) 1 study
Time to effect
Median: 3 months · IQR 3 months3 months · Range 3 months3 months — Reported in 1 of 3 studies
3 of 3 papers
Back to top